Prevalence of Metabolic Syndrome among Working Adults in Ethiopia by Tran, A. et al.
SAGE-HindawiAccess to Research
International Journal of Hypertension
Volume 2011, Article ID 193719, 8 pages
doi:10.4061/2011/193719
Research Article
Prevalence ofMetabolic Syndrome among Working
AdultsinEthiopia
A.Tran,1 B. Gelaye,1 B. Girma,2 S.Lemma,2 Y. Berhane,2 T. Bekele,3
A.Khali,3 and M. A.Williams1
1Multidisciplinary International Research Training Program, Department of Epidemiology, University of Washington School
of Public Health, Seattle, WA 98195, USA
2Addis Continental Institute of Public Health, Addis Ababa, Ethiopia
3International Clinical Laboratories, Addis Ababa, Ethiopia
Correspondence should be addressed to B. Gelaye, mirt@uw.edu
Received 27 January 2011; Accepted 27 March 2011
Academic Editor: Kazuko Masuo
Copyright © 2011 A. Tran et al. This is an open access article distributed under the Creative CommonsAttribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective. To evaluate the prevalence of metabolic syndrome (MetS) according to the International Diabetes Federation (IDF)
and Adult Treatment Panel (ATP) III criteria among working East African adults. Design. This cross-sectional study of 1,935
individuals(1,171menand764women)wasconducted amongworkingadultsinAddis Ababa,Ethiopia.The study wasconducted
in accordance with the STEPwise approach of the World Health Organization. Results. According to ATP III and IDF deﬁnitions,
the overall prevalence of MetS was 12.5% and 17.9%, respectively. Using ATP III criteria, the prevalence of MetS was 10.0% in
men and 16.2% in women. Application of the IDF criteria resulted in a MetS prevalence of 14.0% in men and 24.0% in women.
The most common MetS components among women were reduced high-density lipoprotein-cholesterol (HDL-C) (23.2%) and
abdominalobesity (19.6%);whilst reduced HDL-C concentrations (23.4%) and high blood pressure (21.8%) were mostcommon
among men. Conclusion. MetS and its individual components are prevalent among an apparently healthy working population
in Ethiopia. These ﬁndings indicate the need for evidence-based health promotion and disease prevention programs; and more
robust eﬀorts directed towards the screening, diagnosis and management of MetS and its components among Ethiopian adults.
1.Introduction
The global prevalence of chronic noncommunicable diseases
(NCDs) is on the rise, with the majority of the growth
occurringamong populationsin developingcountries[1].In
sub-SaharanAfrica,NCDsareprojectedtosurpassinfectious
diseases by 2030 [2, 3]. Metabolic syndrome (MetS) is a
constellation of risk factors of cardiovascular disease (CVD)
such as diabetes and impaired glucose regulation, central
obesity, hypertension, and dyslipidemia [4]. Consumption
ofcalorie-dense foods, sedentary lifestyle, tobaccoconsump-
tion, and use of antiretroviral medications are risk factors
for MetS [5–10]. Limited available evidence suggests an in-
creasing prevalence of MetS among populations in sub-
Saharan African countries over the past decade [11].
Information concerning the prevalence and risk factors
of MetS among sub-Saharan Africa is sparse, as most studies
have been conducted in North America, Europe, and Asia
[12–17]. To the best of our knowledge, no study has system-
atically evaluated the prevalence of MetS among Ethiopians.
Currently, there are four widely used deﬁnitions for
MetS, and there appears to be no consensus about the appli-
cation of any one diagnostic criteria [18]. We evaluated the
prevalenceofMetSusing the NationalCholesterol Education
Program Adult Treatment Panel III (ATP III) [19]a n dt h e
International Diabetes Federation (IDF) [20], two of the
most widely used deﬁnitions of MetS. Both deﬁnitions
consider blood glucose impairment (hyperglycemia), excess
abdominal/body fat (increased waist and/or obesity), dys-
lipidemia (low HDL-cholesterol and/or high triglycerides),
and elevated blood pressure to be core criteria of MetS
[11]. While similar, the deﬁnitions have diﬀerent crite-
ria and cut-oﬀ values and may yield diﬀering outcomes
[21].2 International Journal of Hypertension
2.Materialsand Methods
2.1. Design and Participants. This study was conducted in
Addis Ababa, the capital city of Ethiopia during the months
of December 2009 and January 2010. Study subjects were
current permanent employees of the Commercial Bank of
Ethiopia (CBE)and teachers in government schools of Addis
Ababa. Workplaces were selected based on their relatively
high stability of workforce and willingness to participate
in the study. A multistage, probabilistic stratiﬁed sampling
strategy was used to identify and recruit participants. Prob-
ability proportional to size (PPS) sampling procedures were
used to select CBE branch oﬃces and schools. All employees
of the selected workplaces were invited to participate in
the study. Excluding subjects with missing anthropometric
information (n = 22), pregnant women (n = 21), and
individuals without laboratory measures (n = 227), the ﬁnal
sample size included 1,935 (1,171 men and 764 women)
participants.
This study was conducted in accordance with the STEP-
wise approach of the World Health Organization (WHO)
for NCD surveillance in developing countries [22]. The
approach has three levels: (1) questionnaire to gather demo-
graphic and behavioral information, (2) simple physical
measurements, and (3) biochemical tests.
2.2. Data Collection and Variable Speciﬁcation. Participants
were interviewed by trained interviewers using the WHO
STEPS-structured questionnaire. In accordance with the
STEPS manual, questions related to alcohol and substance
use were tailored to reﬂect the local context of Ethiopia [22].
A few additional questions were added to supplement the
questionnaire and to reﬂect the local context of Ethiopia.
Thequestionnairewasﬁrst writteninEnglish, translatedinto
Amharic by experts, and translated back into English by a
panel of professionals who speak both languages. The ques-
tionnaire was pretested before the initiation of the study and
contained information regarding sociodemographic charac-
teristics, tobacco and alcohol use, nutritional status, and
physical activity. A ﬁve-day training of the contents of the
STEPS questionnaire, data collection techniques, and ethical
conduct of human research was provided to research inter-
viewers prior to the commencement on the study.
Physical/anthropometric examinations and blood sam-
ple collections were carried out by trained research nurses.
Blood pressure (BP) was measured using a digital measuring
device (Microlife BP A50, Microlife AG, Switzerland) with
participants sitting after resting for at least ﬁve minutes.
Three BP measurements were taken with at least three-
minute intervals between consecutive measurements. The
mean systolic and diastolic BP from the second and third
measurements were analyzed [22]. The weights of the par-
ticipants were measured using a solar-powered scale (Model
871,Seca, Germany). Heightand weight were measured with
participants wearing light clothing. Waist circumference was
taken at the midpoint between the lower margin of the
last palpable rib and the top of the iliac crest (hip bone)
[22]. Hip circumference was taken around the maximum
circumference of the buttocks [22].
Blood samples were collected after a 12-hour overnight
fasting. Samples of 12mL of blood were obtained from
each participant employing standard infection prevention
procedures. The collected aliquots of blood serum were used
todetermineparticipants’fasting glucoseconcentrationsand
lipid proﬁles. Serum triglycerides (TGs), total cholesterol
(TC), high-density lipoprotein cholesterol (HDL-C), low-
density lipoprotein cholesterol (LDL-C), and fasting serum
glucose (FG) were measured at the International Clinical
Laboratory (ICL) in Addis Ababa, Ethiopia. ICL is one of the
best equipped laboratories in Ethiopia with internationally
accredited standard operating procedures. TG concentra-
tions were determined by standardised enzymatic proce-
dures using glycerol phosphate oxidase assay. HDL-C was
measured using Ultra-HDL assay which is a homogeneous
method for directly measuring HDL-C concentrations in
serum plasma without the need for oﬀ-line pretreatment or
centrifugation steps. Participants’ FG was determined using
standardized glucose oxidase method. All laboratory assays
were completed without knowledge of participants’ medical
history. Lipid, lipoprotein, and FG concentrations were
reported as mg/dL.
Prevalence of MetS was deﬁned according to the IDF and
ATP III criteria outlined below.
IDF Deﬁnition. In accordance with the IDF criteria, subjects
were classiﬁed as having MetS if participants had abdominal
obesity (deﬁned as waist circumference of ≥94cm for men
and ≥80cm women) plus two of any of the following
risk factors: (1) raised TG level (≥150mg/dL) or speciﬁc
treatment for this lipid abnormality; (2) reduced HDL-
C( <40mg/dL in males and <50mg/dL in females) or
speciﬁc treatment forthislipid abnormality; (3)raised blood
pressure (systolic BP ≥130 or diastolic BP ≥85mmHg) or
treatment of previously diagnosed hypertension; (4) raised
FG (≥100mg/dL) or previously diagnosed with type 2
diabetes.
ATP III Deﬁnition. In accordance with the ATP III criteria,
subjects were classiﬁed as having MetS if participants
had three or more of the following risk factors: (1)
abdominal obesity (waist circumference >102cm in males
and >88cm in females); (2) hypertriglyceridemia (TG
≥150mg/dL); (3) reduced HDL-C (<40mg/dL in males and
<50mg/dL in females); (4) high BP (≥130/85mmHg); (5)
FG (≥110mg/dL).
All subjects provided informed consent, and all research
protocols were approved by the Institutional Review Boards
ofAddisContinentalInstituteofPublicHealth,AddisAbaba,
Ethiopia and the Human Subjects Division at the University
of Washington, USA.
2.3. Statistical Analyses. Data were entered into EPI INFO
(Version 3.5.1), a public access software made available
from the U.S. Centers for Disease Control and Prevention
(CDC). Entered data were exported to PASW Statistics
(Version 18.0) for statistical analysis. We ﬁrst explored
frequency distributions of sociodemographical, clinical, andInternational Journal of Hypertension 3
Table 1:Sociodemographiccharacteristics ofthestudy population.
Characteristic
Men Women
P value N = 1,171 N = 764
%%
Age (years)






≤High school 4.0 6.2 <.001
Technical school 4.1 16.1
≥ Bachelors 91.9 77.7
Smokingstatus
Never smoker 78.9 99.2 <.001
Pervious smoker 14.0 0.7
Current smoker 7.1 0.1
Religion




Alcohol consumption in past year
Less than once a month 65.5 95.4 <.001
1–4 days a week 29.7 3.3
5-6 days a week 2.8 0.7
Daily 2.1 0.7
Khat chewing
No 86.3 99.3 <.001
Yes 13.7 0.7
Self-reported health status
Poor/Fair 35.8 41.8 <.001
Excellent 64.2 58.2
behavioural characteristics of subjects. Continuous variables
were expressed as mean ± standard deviation. For skewed
variables, median ± interquartile range was reported. Cat-
egorical variables were expressed as number (percentage,
%). Chi-square tests were used to evaluate the diﬀerences
in the distribution of categorical variables for study groups.
Student’st-testswere usedtoevaluatediﬀerencesinmeanfor
study groups. The prevalence estimates for MetS according
to the two deﬁnitions were determined separately. Using
previously described methods, 95% conﬁdence intervals for
prevalence estimates were determined [23]. All reported P
valuesare twotailed,and statisticalsigniﬁcance was setat .05
levels.
3.Results
Demographic and lifestyle characteristics of the study popu-
lation are provided in Table 1. The majority of participants
had a college diploma, bachelor’s degree, or higher (91.9%
men and 77.7% women) and reported to be Orthodox
Christians (79.0% men and 80.6% women). Approximately
20.0% of men and less than 1.0% of women reported
that they were current or previous smokers; of 4.9% men
and 1.5% of women reported almost daily or daily alcohol
consumption during the past year. Khat chewing (a natural
stimulant with amphetamine-like eﬀects commonly used for
social recreationin East African countries) [24]w a sr e p o r t e d
by 13.7% of men and 0.7% of women. Approximately 36.0%
of men and 42.0% of women reported having a fair or poor
health status.
Table 2 shows the cardiometabolic and clinical character-
istics of the study population. Approximately, a quarter of
men (24.7%) and women (25.7%) were overweight (BMI
25.0–29.9kg/m2). Women were more likely to be obese
(10.2%) compared to men (2.1%). Approximately 46.0% of
men and 31.0% of women were prehypersensitive (systolic
BP 120–130mmHg or diastolic BP 80–89mmHg); 15.6%
of men and 10.8% of women had stage 1 hypertension
(systolic BP 140–159mmHg or diastolic BP 90–99mmHg).
The mean systolic blood pressure and diastolic blood
pressurewerehigherformen(124.3mmHg)thanforwomen
(116.5mmHg). Men also had a higher mean waist cir-
cumference compared with women. Fasting serum glucose
concentrations were similar for both groups. However,
mean serum HDL-C and LDL-C concentrations were higher
among women as compared with men. Serum triglyceride
concentrations were higher, on average, among men as com-
pared with women.
Table 3 shows the prevalence of MetS as deﬁned using
the ATP III and IDF diagnostic criteria. Using the ATP III
criteria, the prevalence of MetS was 12.5% overall (10.0%
among men and 16.2% among women) in the study popula-
tion. Application of the IDF criteria in this study population
yielded a MetS prevalence of 17.9% overall (14.0% of men
and 24.0% of women). The prevalence of MetS, irrespective
of criteria used, increased markedly with age in both men
and women. However, the prevalence was highest between
ages 45–54 with 40.5% of men and 53.7% of women having
MetS.
The age-adjusted prevalence estimates of each compo-
nent of MetS according to the ATP III and IDF criteria are
summarized in Figure 1. The most common MetS compo-
nents among women using the ATP III criteria were reduced
HDL-C (23.2%) and abdominal obesity (19.6%), whilst
reduced HDL-C concentrations (23.4%) and high blood
pressure (21.8%) were most common among men. Similar
patternswere observedusing the IDFcriteria. Figure 2 shows
t h ep r e s e n c eo f0 ,1 ,2 ,3 ,4 ,a n d5M e t Sc o m p o n e n t sa m o n g
men and women using the ATP III criteria and the presence
of 0, 1, 2, 3, and 4 components in addition to central obesity
as a requirement among men and women using the IDF
deﬁnition. While some participants did not meet the MetS
criteria of the ATP III and IDF, many had one or two
components and may be at risk of developing the syndrome
in thefuture.Using theATP IIIcriteria,20.4%ofwomenand
18.6% of men had two MetS components. The IDF criteria
also showed a high number of individuals at risk with 46.5%
of women and 34.7% of men having central obesity plus one
additional component.4 International Journal of Hypertension
Table 2: Cardiometabolic characteristics of study population according to gender.
Characteristic
Gender
P value Men Women
N = 1,171% N = 764%
Body mass index (kg/m2)
Underweight (<18.5) 13.2 11.9 <.001
Normal (18.5–24.9) 59.9 52.2
Overweight (25.0–29.9) 24.7 25.7
Obese (≥30.0) 2.1 10.2
Blood pressure∗
Normotensive 34.4 55.2 <.001
Prehypertension 45.6 30.6
Stage 1 hypertension 15.6 10.8
Stage 2 hypertension 4.4 3.5
Mean (SD) Mean (SD)
Waist circumference 85.6 (11.3) 80.6 (12.9) <.001
Diastolic blood pressure (mmHg) 80.1 (14.6) 76.3 (10.3) <.001
Systolic blood pressure (mmHg) 124.3 (16.0) 116.5 (17.0) <.001
Mean arterial pressure 94.8 (13.4) 89.7 (11.8) <.001
Fasting glucose (mg/dL) 94.3 (28.7) 93.5 (26.7) .654
HDL cholesterol (mg/dL) 45.4 (8.4) 50.3 (10.5) <.001
LDL cholesterol (mg/dL) 115.3 (44.9) 119.8 (34.7) .908
Median (IQ) Median (IQ)
Triglycerides (mg/dL)† 112.0 (81.0–171.0) 95.0 (72.0–127.0) .127
†Data are median (interquartile range) since distribution was skewed, and test of signiﬁcance was based on log-transformed values.
∗According to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, hypertension is classiﬁed by the
following standards: (1) normotensive (systolicBP < 120mmHg and diastolic BP < 80mmHg); (2) prehypertension (systolicBP 120–139mmHg or diastolic
BP80–89mmHg);stage1 hypertension (systolicBP140–159mmHgor diastolicBP90–99mmHg);stage2hypertension (systolicBP ≥160mmHgordiastolic
BP ≥100mmHg) [25].
Table 3: Prevalence of metabolic syndrome based on diﬀerent sets of criteria by age group.
Adult Treatment Panel (ATP) III
All Men (N = 1171)
% (95% CI)
Women (N = 764)
% (95% CI)
Overall 12.5 (11.0–14.0) 10.0 (8.3–11.7) 16.2 (13.6–18.8)
Age (years)
≤24 2.5 (0.9–4.1) 1.7 (0.1–3.5) 3.3 (0.6–6.0)
25–34 7.9 (5.9–9.9) 9.5 (6.8–12.2) 6.5 (3.4–9.6)
35–44 18.4 (14.2–22.6) 21.6 (15.8–27.4) 15.4 (9.2–21.6)
45–54 47.3 (42.2–52.4) 40.5 (33.8–47.2) 53.7 (46.2–61.2)
≥55 23.8 (17.5–30.1) 26.7 (18.8–34.6) 21.1 (9.9–32.3)
International Diabetes Federation (IDF)
Men (N = 1171)
% (95% CI)
Women (N = 764)
% (95% CI)
Overall 17.9 (16.2–19.6) 14.0 (12.0–16.0) 24.0 (21.0–27.0)
Age (years)
≤24 2.6 (1.0–4.2) 1.2 (10.3–20.1) 3.9 (1.0–6.8)
25–34 12.5 (10.0–15.0) 14.7 (11.9–18.5) 10.5 (6.6–14.4)
35–44 20.9 (16.5–25.3) 20.9 (10.1–20.3) 21.0 (14.0–28.0)
45–54 43.3 (38.3–48.3) 38.0 (10.3–20.1) 48.1 (40.6–55.6)
≥55 20.6 (14.6–26.6) 25.2 (8.8–21.6) 16.6 (6.4–26.8)International Journal of Hypertension 5
A b
d o
m i n a
l
































  f a s t
i
n g




























m i s n a
l
































  f a s t
i
n g




















Figure 1: Age-adjusted prevalence of metabolic syndrome compo-
















































Figure 2: Number of metabolic syndrome components by gender
according to ATP III and IDF criteria.
4.Discussion
Findings from this study conﬁrm a high prevalence of MetS
among working adults in Addis Ababa, Ethiopia. Using the
ATP III criteria, the prevalence of MetS was found to
be 12.5%, while the IDF criteria yielded an even higher
prevalence of 17.9%. Our results suggest that women are at
greater risk for MetS (ATP III 16.2% and IDF 24.0%) than
men (ATP III 10.0% and IDF 14.0%). The prevalence of
MetS increased markedly with age. MetS was most prevalent
among participants in the 45–54 age group (43.3%–47.3%).
Lastly, the number of participants with one or two MetS
components suggests that certain individuals are potentially
at risk of developing the syndrome.
Little information exists concerning the prevalence and
epidemiological characteristics of MetS in sub-Saharan6 International Journal of Hypertension
Africa. The ﬁrst reported MetS study in the region was
conductedin themid-90sinCameroon[12,26]whichfound
a 1.5% and 1.3% prevalence of MetS among urban dwelling
women and men using IDF criteria [26]; however, the study
did not measure HDL-C concentrations. A second study
conducted in 2004 by Kelliny et al., in Seychelles, found
a high prevalence of MetS where 25%–30% of their study
population had the syndrome [11]. A recent study involving
adults in semiurban and rural communities in Nigeria
found a prevalence of MetS to be 18% [27]. A community-
based study conducted in Tanzania in 2009 reported a 38%
prevalence of MetS although the study sample size was small
[28]. More recently, Adegoke et al. in their study among
rural Nigerians reported a 12.1% prevalence of MetS [29].
Our prevalence estimates are higher than what was reported
in Cameroon and rural Nigeria [26, 29]b u tl o w e rt h a n
Seychelles and Tanzania [11, 28]. Our study ﬁndings were
lower than other reports of MetS prevalence of developed
countries over the last few years including the USA [15],
Portugal [30], and Turkey [31]. However, the results of our
study were greater than the prevalence of MetS in some
developed countries such as Japan [14]a n dC h i n a[ 13].
While there is no unanimously accepted deﬁnition of MetS,
ﬁndings from this study resulted in a high prevalence of MetS
regardless of the deﬁnition (ATP III or IDF) used. Many
recent studies have evaluated MetS prevalence using more
than one deﬁnition including those established by ATP III,
IDF, and WHO [11, 29].
Previous studies conducted in sub-Saharan Africa in-
cluding in Benin and in south-western Nigeria have iden-
tiﬁed a high prevalence of cardiometabolic risk factors
including abdominal obesity (32.0% and 14.7%, resp.) and
hypertension (23.0% and 28.0%, resp.) [32, 33]. While there
is an accumulating body of evidence on the prevalence of the
individual components of MetS among Ethiopians [34–36],
to the best of our knowledge, this is the ﬁrst study to report
the prevalence of the syndrome in the country. Tesfaye et
al., in their cross-sectional study involving adults in Addis
Ababa, Ethiopia, found a high prevalence of hypertension
(31.5%among menand 28.9%among women)asacausefor
concern [34]. The same study also found a high prevalence
of overweight adults and indicated that women were more
likely to be overweight than men in their study population
[34]. Our ﬁndings of high prevalence of MetS and its
components are in part due to the epidemiological and
nutritional transition that has occurred globally including in
sub-Saharan African countries where lifestyle and behavioral
changes, both products of modernization and urbanization,
have taken place [37–40]. As a result of this epidemiological
transition where CVD risk in Africa is increasing [41],
preventative measures as well as interventional programs are
in demand.
O u rs t u d yh a ss e v e r a ls t r e n g t h si n c l u d i n gt h en u m b e ro f
participants which was adequate to make gender- and age-
speciﬁc comparisons, the inclusion of schools and branch
oﬃces in wider geographical areas, the use of standard and
calibrated instruments to make measurements, the require-
ment of reliability tests before data collection, and standard-
ization during training. Limitations of our study include
social desirability bias in which participants may withhold
information regarding their life-style habits that may not be
generally acceptable for working adults (smoking, chewing
khat, etc.) [42] which may result in an underestimation
of these behaviors. In addition, study ﬁndings may not be
generalized to the broader Ethiopian population since study
subjects consisted of current employed bankers of CBE
and teachers in government schools who were fairly well-
educated and urban workers.
In conclusion, the prevalence of MetS among our study
population was high and ultimately adds to the limited
amount of MetS data in sub-Saharan Africa. An increased
risk for cardiovascular morbidity and mortality has also
been linked to the prevalence of MetS [43]. The ﬁndings
highlight the need for evidence-based prevention, diagnosis,
and management of MetS and its associated factors among
working adults in Ethiopia. Individuals with and at risk of
MetS ought to focus on weight management and engage in
appropriate physical activity levels. Support and promotion
of healthy lifestyle behaviors by institutional leaders are also
highly desirable. Moreover, future interventions by health
policy makers and public health oﬃcials ought to focus
on the individuals at risk for MetS who have one or two
risk factors in order to control any potential burden of the
syndrome.
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